Journal of Pharmacology and Experimental Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q2 | 73.6% | 0.921 | Q2 | 81.7% |
| 2024 | 3.8 | Q2 | 74.2% | 1.108 | Q1 | 86.7% |
| 2023 | 3.1 | Q2 | 65.9% | 0.829 | Q2 | 80.8% |
| 2022 | 3.5 | Q2 | 64.3% | 0.972 | Q1 | 85.6% |
| 2021 | 4.4 | Q2 | 73.5% | 0.951 | Q1 | 85.5% |
| 2020 | — | — | 1.286 | Q1 | 90.1% | |
| 2019 | — | — | 1.148 | Q1 | 88.5% | |
| 2018 | — | — | 1.383 | Q1 | 90.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0022-3565
ISSN
1521-0103
country
UScoverage
1943, 1945-2026